{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:42:34Z","timestamp":1761972154116,"version":"build-2065373602"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,11,1]]},"DOI":"10.2169\/internalmedicine.5171-24","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T18:07:44Z","timestamp":1744999664000},"page":"3135-3139","source":"Crossref","is-referenced-by-count":0,"title":["Acute Myeloid Leukemia with &lt;i&gt;MYC&lt;\/i&gt; Amplification on a Ring Chromosome 8"],"prefix":"10.2169","volume":"64","author":[{"given":"Yuta","family":"Baba","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Sakai","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nodoka","family":"Maeda","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maasa","family":"Abe","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Kabasawa","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Dang CV. <i>MYC<\/i> on the path to cancer. Cell 149: 22-35, 2012.","DOI":"10.1016\/j.cell.2012.03.003"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Stine ZE, Walton ZE, Altman BJ, Hsieh AL, Dang CV. MYC, metabolism, and cancer. Cancer Discov 5: 1024-1039, 2015.","DOI":"10.1158\/2159-8290.CD-15-0507"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Storlazzi CT, Fioretos T, Surace C, et al. <i>MYC<\/i>-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of <i>MYC<\/i> as the target gene. Hum Mol Genet 15: 933-942, 2006.","DOI":"10.1093\/hmg\/ddl010"},{"key":"4","unstructured":"4. Arber DA, Brunning RD, Orazi A, et al. Acute myeloid leukemia, not other specified. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Swerdlow SH, Campo E, Harris NL, et al., Eds. International Agency for Research on Cancer, Lyon, 2017: 156-166."},{"key":"5","unstructured":"5. Yeung CCS, Ketterling RP, Bullinger L, et al. Acute myeloid leukemia with <i>RUNX1::RUNX1T1<\/i> fusion. In:  WHO Classification of Tumours. 5th ed. Haematolymphoid Tumours Part A. WHO Classification of Tumours Editorial Board, Ed. International Agency for Research on Cancer, Lyon, 2024: 115-117."},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Ott G, Rosenwald A, Campo E. Understanding <i>MYC<\/i>-driven aggressive B-cell lymphomas: pathogenesis and classification. Blood 122: 3884-3891, 2013.","DOI":"10.1182\/blood-2013-05-498329"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gao L, Saeed A, Golem S, et al. High-level MYC expression associates with poor survival in patients with acute myeloid leukemia and collaborates with overexpressed p53 in leukemic transformation in patients with myelodysplastic syndrome. Int J Lab Hematol 43: 99-109, 2021.","DOI":"10.1111\/ijlh.13316"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Dahiya R, Hu Q, Ly P. Mechanistic origins of diverse genome rearrangements in cancer. Semin Cell Dev Biol 123: 100-109, 2022.","DOI":"10.1016\/j.semcdb.2021.03.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mandahl N, Mertens F, Mitelman F. Gene amplification in neoplasia: a cytogenetic survey of 80 131 cases. Genes Chromosomes Cancer 63: e23214, 2024.","DOI":"10.1002\/gcc.23214"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wang C, Zhang J, Yin J, et al. Alternative approaches to target Myc for cancer treatment. Signal Transduct Target Ther 6: 117, 2021.","DOI":"10.1038\/s41392-021-00500-y"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yamamoto K, Kawamoto S, Kurata K, et al. <i>MYC<\/i> amplification in the form of ring chromosomes 8 in acute myeloid leukemia with t(11;16)(q13;p11.2). Cytogenet Genome Res 153: 131-137, 2017.","DOI":"10.1159\/000486328"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rayeroux KC, Campbell LJ. Gene amplification in myeloid leukemias elucidated by fluorescence in situ hybridization. Cancer Genet Cytogenet 193: 44-53, 2009.","DOI":"10.1016\/j.cancergencyto.2009.04.006"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Turner KM, Deshpande V, Beyter D, et al. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature 543: 122-125, 2017.","DOI":"10.1038\/nature21356"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Wu S, Turner KM, Nguyen N, et al. Circular ecDNA promotes accessible chromatin and high oncogene expression. Nature 575: 699-703, 2019.","DOI":"10.1038\/s41586-019-1763-5"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Bernardin F, Yang Y, Civin CI, Friedman AD. c-Myc overcomes cell cycle inhibition by CBF\u03b2-SMMHC, a myeloid leukemia oncoprotein. Cancer Biol Ther 1: 492-496, 2002.","DOI":"10.4161\/cbt.1.5.163"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Slovak ML, Ho JP, Pettenati MJ, et al. Localization of amplified MYC gene sequences to double minute chromosomes in acute myelogenous leukemia. Genes Chromosomes Cancer 9: 62-67, 1994.","DOI":"10.1002\/gcc.2870090111"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chen P, Redd L, Schmidt Y, et al. MYC protein expression does not correlate with <i>MYC<\/i> abnormalities detected by FISH but predicts an unfavorable prognosis in <i>de novo<\/i> acute myeloid leukemia. Leuk Res 106: 106584, 2021.","DOI":"10.1016\/j.leukres.2021.106584"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-<i>myc<\/i> is inhibited by <i>bcl<\/i>-2. Nature 359: 552-554, 1992.","DOI":"10.1038\/359552a0"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359: 554-556, 1992.","DOI":"10.1038\/359554a0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Li Z, Zhang L, Liu D, Yang Z, Xuan D, Zhang Y. Knockdown of NRMT enhances sensitivity of retinoblastoma cells to cisplatin through upregulation of the CENPA\/Myc\/Bcl2 axis. Cell Death Discov 8: 14, 2022.","DOI":"10.1038\/s41420-021-00622-w"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Han JY, Theil KS, Hoeltge G. Frequencies and characterization of cytogenetically unrelated clones in various hematologic malignancies: seven years of experiences in a single institution. Cancer Genet Cytogenet 164: 128-132, 2006.","DOI":"10.1016\/j.cancergencyto.2005.07.013"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Stark B, Jeison M, Gobuzov R, et al.  Apparently unrelated clones shown by spectral karyotyping to represent clonal evolution of cryptic t(10;11)(p13;q23) in a patient with acute monoblastic leukemia. Cancer Genet Cytogenet 120: 105-110, 2000.","DOI":"10.1016\/S0165-4608(00)00211-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Al-Harbi S, Aljurf M, Mohty M, Almohareb F, Ahmed SOA. An update on the molecular pathogenesis and potential therapeutic targeting of AML with t(8;21)(q22;q22.1);<i>RUNX1-RUNX1T1<\/i>. Blood Adv 4: 229-238, 2020.","DOI":"10.1182\/bloodadvances.2019000168"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/21\/64_5171-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T03:26:37Z","timestamp":1761967597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/21\/64_5171-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":23,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5171-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"article-number":"5171-24"}}